CERO THERAPEUTICS HOLDINGS, INC. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b3bab0c8-e85b-4621-b269-1cc8b7dafff1/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-15.3M | 2024-02-14 – 2024-12-31 | evidence 0001213900-25-032134 |
| FY 2023 | $-7.7M | 2023-01-01 – 2023-12-31 | evidence 0001213900-25-032134 |
| FY 2022 | $-2.9M | 2022-01-01 – 2022-12-31 | evidence 0001213900-24-029051 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).